Serum concentrations of neuropilin-1 in women with endometriosis

References

• Ferrero S, Arena E, Morando A, et al. Prevalence of newly diagnosed endometriosis in women attending the general practitioner. Int J Gynaecol. Obstet. 2010;110(3):203–207.
   PubMed Web of Science ®Google Scholar
• American Society for Reproductive Medicine. 1997 Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril. 1996;67:817–821.
   Web of Science ®Google Scholar
• The Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;101(4):927–935.
   Google Scholar
• Matalliotakis IM, Cakmak H, Fragouli YG, et al. Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet. 2008;277(5):389–393.
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Rizk BR. Endometriosis current management and future trends. St. Louis: Jaypee Brothers; 2010.
   Google Scholar
• Ishimaru T, Masuzaki H. Peritoneal endometriosis: endometrial tissue implantation as its primary etiologic mechanism. Am J Obstet Gynecol. 1991;165(1):210–214.
   PubMed Web of Science ®Google Scholar
• Hey-Cunningham AJ, Peters KM, Barrera-Villa Zevallos H, et al. Angiogenesis, lymphangiogenesis and neurogenesis in endometriosis. Front Biosci. 2013;E5(3):1033–1056.
   Google Scholar
• Pavelock K, Braas KM, Ouafik L, et al. Differential expression and regulation of the vascular endothelial growth factor receptors neuropilin-1 and neuropilin-2 in rat uterus. Endocrinology. 2001;142(2):613–622.
   PubMed Web of Science ®Google Scholar
• Whitaker GB, Limberg BJ, Rosenbaum JS. Vascular endothelial growth factor receptor- 2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J Biol Chem. 2001;276(27):25520–25531.
   PubMed Web of Science ®Google Scholar
• Girling JE, Rogers P. Recent advances in endometrial angiogenesis research. Angiogenesis. 2005;8(2):89–99.
   PubMedGoogle Scholar
• Murga M, Fernandez-Capetillo O, Tosato G. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood. 2005;105(5):1992–1999.
   PubMed Web of Science ®Google Scholar
• He ZG, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell. 1997;90(4):739–751.
   PubMed Web of Science ®Google Scholar
• Kolodkin AL, Levengood DV, Rowe EG, et al. Neuropilin is a semaphorin III receptor. Cell. 1997;90(4):753–762.
   PubMed Web of Science ®Google Scholar
• Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735–745.
   PubMed Web of Science ®Google Scholar
• Kitsukawa T, Shimono A, Kawakami A, et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 1995;121(12):4309–4318.
   PubMed Web of Science ®Google Scholar
• Rocha AL, Reis FM, Taylor RN. Angiogenesis and endometriosis. Obstet Gynecol Int. 2013;2013:1–8.
   Google Scholar
• Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;05:CD012179.
   Google Scholar
• Vinatier D, Orazi G, Cosson M, et al. Theories of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):21–34.
   PubMed Web of Science ®Google Scholar
• Cheng W, Fu D, Wei ZF, et al. NRP-1 expression in bladder cancer and its implications for tumor progression. Tumor Biol. 2014;35(6):6089–6094.
   PubMedGoogle Scholar
• Xu J, Xia J. NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo. Exp Ther Med. 2013;5(1):150–154.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li P, Zhang X, et al. Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma. Diagn Pathol. 2013;8(1):155.
   PubMedGoogle Scholar
• Jubb AM, Strickland LA, Liu SD, et al. Neuropilin-1 expression in cancer and development. J Pathol. 2012;226(1):50–60.
   PubMed Web of Science ®Google Scholar
• Kreuter M, Woelke K, Bieker R, et al. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia. 2006;20(11):1950–1954.
   PubMed Web of Science ®Google Scholar
• Zhao J, Gu L, Li C, et al. Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients. Tumor Biol. 2014;35(7):6919–6924.
   PubMedGoogle Scholar
• Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009;16:140–146.
   PubMed Web of Science ®Google Scholar
• Hey-Cunningham AJ, Markham R, Fraser IS, et al. Dysregulation of vascular endothelial growth factors and their neuropilin receptors in the eutopic endometrium of women with endometriosis. Reprod Sci. 2013;20(11):1382–1389.
   PubMed Web of Science ®Google Scholar
• Yerlikaya G, Balendran S, Pröstling K, et al. Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis. Eur J Obstet Gynecol Reprod Biol. 2016;204:88–98.
   PubMed Web of Science ®Google Scholar
• Sarris M, Andersen KG, Randow F, et al. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity. 2008;28(3):402–413.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Murakami Y, Suto F, et al. Determination of cell adhesion sites of neuropilin-1. J Cell Biol. 2000;148(6):1283–1293.
   PubMed Web of Science ®Google Scholar
• Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5(1):74–80.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xiang H, Liu P, et al. Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administration. MAbs. 2009;1(4):364–369.
   PubMed Web of Science ®Google Scholar